Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: A meta-analysis

Cancer Epidemiology

Volumn 34, Issue 5, 2010, Pages 593-597

  Wang, Yadong ^a   Yang, Haiyan ^b   Li, Li ^a   Wang, Haiyu ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Genetic polymorphism; GSTT1; Lung cancer; Meta analysis

Indexed keywords

GLUTATHIONE TRANSFERASE T1;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GSTT1 GENE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 77957222264     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.05.008     Document Type: Article

References (56)

1. Voicu-Maceseanu A., Nitu M., Olteanu M., Bica D. Epidemiology of lung cancer. Pneumologia 2007, 56:78-84.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
3. Zhao P., Dai M., Chen W., Li N. Cancer trends in China. Jpn J Clin Oncol 2010, 40:281-285.
4. Cote M.L., Chen W., Smith D.W., Benhamou S., Bouchardy C., Butkiewicz D., et al. Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2009, 169:802-814.
5. Kiyohara C., Yoshimasu K., Shirakawa T., Hopkin J.M. Genetic polymorphisms and environmental risk of lung cancer: a review. Rev Environ Health 2004, 19:15-38.
6. Schabath M.B., Spitz M.R., Hong W.K., Delclos G.L., Reynolds W.F., Gunn G.B., et al. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 2002, 37:35-40.
7. Shields P.G., Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000, 18:2309-2315.
8. Shah P.P., Singh A.P., Singh M., Mathur N., Pant M.C., Mishra B.N., et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 2008, 639:1-10.
9. Voho A., Metsola K., Anttila S., Impivaara O., Jarvisalo J., Vainio H., et al. EPHX1 gene polymorphisms and individual susceptibility to lung cancer. Cancer Lett 2006, 237:102-108.
10. Chiou H.L., Wu M.F., Chien W.P., Cheng Y.W., Wong R.H., Chen C.Y., et al. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer Lett 2005, 223:93-101.
11. Sorensen M., Autrup H., Tjonneland A., Overvad K., Raaschou-Nielsen O. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett 2005, 221:185-190.
12. Yang X.R., Wacholder S., Xu Z., Dean M., Clark V., Gold B., et al. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett 2004, 214:197-204.
13. Laforest L., Wikman H., Benhamou S., Saarikoski S.T., Bouchardy C., Hirvonen A., et al. CYP2D6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. Eur J Cancer 2000, 36:1825-1832.
14. Jemth P., Mannervik B. Kinetic characterization of recombinant human glutathione transferase T1-1, a polymorphic detoxication enzyme. Arch Biochem Biophys 1997, 348:247-254.
15. Meyer D.J. Significance of an unusually low Km for glutathione in glutathione transferases of the alpha, mu and pi classes. Xenobiotica 1993, 23:823-834.
16. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000, 463:247-283.
17. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994, 300(Pt 1):271-276.
18. Yuan T., Zhou Q., Zhu W., Guo Z., Li P., Wang Y., et al. Relationship between genetic polymorphism of GSTTI gene and inherent susceptibility to lung cancer in Han population in Sichuan, China. Chin J Lung Cancer 2005, 8:107-111.
19. Liang G., Pu Y., Yin L. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Hereditas (Beijing) 2004, 26:584-588.
20. Cao Y., Chen H., Liu X., Liu Q., Zhang J., Wu Y., et al. Study on the relationship between the genetic polymorphisms of GSTM 1 and GSTT 1 genes and lung cancer susceptibility in the population of Hunan Province of China. Life Sci Res 2004, 8:126-132.
21. Chan-Yeung M., Tan-Un K.C., Ip M.S., Tsang K.W., Ho S.P., Ho J.C., et al. Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer 2004, 45:155-160.
22. Hosgood H.D., Berndt S.I., Lan Q. GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res 2007, 636:134-143.
23. Lee K.M., Kang D., Clapper M.L., Ingelman-Sundberg M., Ono-Kihara M., Kiyohara C., et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 2008, 17:1120-1126.
24. Raimondi S., Paracchini V., Autrup H., Barros-Dios J.M., Benhamou S., Boffetta P., et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006, 164:1027-1042.
25. Ye Z., Song H., Higgins J.P., Pharoah P., Danesh J. Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006, 3:e91.
26. Hu Z., Jin G., Wang L., Chen F., Wang X., Shen H. MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studies. Cancer Epidemiol Biomarkers Prev 2007, 16:2717-2723.
27. Lan Q., He X., Debra C., Tian W., Lu X., Judy M. Glutathione S transferase GSTM 1 and GSTT 1 genotypes and susceptibility to lung cancer. J Hyg Res 1999, 28:9-11.
28. Yao W., Wang N., Wu Y., Wu Y. Relationship between deletion of GSTM1, GSTTI genes and susceptibility to lung cancer. Chin J Public Health 2006, 22:1070-1072.
29. Zhang J., Hu Y., Hu C., Wang S. Study on genetic polymorphisms of GSTM 1 and GSTT1 related with inherent susceptibility to lung cancer in women. Chin J Public Health 2002, 18:273-275.
30. Chen H.C., Cao Y.F., Hu W.X., Liu X.F., Liu Q.X., Zhang J., et al. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Dis Markers 2006, 22:141-152.
31. Liang K., Zheng C., Gan C. Polymorphisms of GSTM1 and GSTT1 genes and lung cancer susceptibility. Acta Med Sinica 2009, 22:579-582.
32. Lan Q., He X., Costa D.J., Tian L., Rothman N., Hu G., et al. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev 2000, 9:605-608.
33. London S.J., Yuan J.M., Chung F.L., Gao Y.T., Coetzee G.A., Ross R.K., et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 2000, 356:724-729.
34. Zhao B., Seow A., Lee E.J., Poh W.T., Teh M., Eng P., et al. Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 2001, 10:1063-1067.
35. Zhang J., Hu Y., Hu C., Wang S. Relationship between genetic polymorphisms of GSTM1 as well as GSTT1 and lung cancer. Chin J Pathophysiol 2002, 18:352-355.
36. Wang J., Deng Y., Cheng J., Ding J., Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003, 201:185-193.
37. Wang N., Wu Y., Wu Y., Zhuang D. Research on relationship between deletion of GSTM1, GSTTI genes and susceptibility to lung cancer. J Hyg Res 2004, 33:586-588.
38. Qi X., Lv H., Xia Y., Shang B., Sun Q., Cui H., et al. A primary case-control study on the relationship between genetic polymorphisms of GSTT1 and lung cancer susceptibility to the people living in high radon-exposed area. Chin Occup Med 2008, 35:361-367.
39. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
40. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
41. Shi X., Zhou S., Wang Z., Zhou Z., Wang Z. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 2008, 59:155-163.
42. Xu T., Li X., Wang W., Hu P., Du F. Detection of publication bias in meta-analysis of dichotomous variable-Egger test and Begg test. J Evid Based Med 2009, 19:181-184.
43. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
44. To-Figueras J., Gene M., Gomez-Catalan J., Galan M.C., Fuentes M., Ramon J.M., et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 1997, 18:1529-1533.
45. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988, 202:343-361.
46. Ketterer B., Harris J.M., Talaska G., Meyer D.J., Pemble S.E., Taylor J.B., et al. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 1992, 98:87-94.
47. Grubben M.J., Nagengast F.M., Katan M.B., Peters W.H. The glutathione biotransformation system and colorectal cancer risk in humans. Scand J Gastroenterol Suppl 2001, 68-76.
48. Landi S., Norppa H., Frenzilli G., Cipollini G., Ponzanelli I., Barale R., et al. Individual sensitivity to cytogenetic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics 1998, 8:461-471.
49. Norppa H., Hirvonen A., Jarventaus H., Uuskula M., Tasa G., Ojajarvi A., et al. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis 1995, 16:1261-1264.
50. Casson A.G., Zheng Z., Chiasson D., MacDonald K., Riddell D.C., Guernsey J.R., et al. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 2003, 27:139-146.
51. Rossini A., Rapozo D.C., Soares Lima S.C., Guimaraes D.P., Ferreira M.A., Teixeira R., et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. Carcinogenesis 2007, 28:2537-2542.
52. Boccia S., La Torre G., Gianfagna F., Mannocci A., Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis 2006, 21:115-123.
53. White D.L., Li D., Nurgalieva Z., El-Serag H.B. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 2008, 167:377-389.
54. Wan H., Zhou Y., Yang P., Chen B., Jia G., Wu X. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: a meta-analysis. Cancer Epidemiol 2010, 34:66-72.
55. Abdel-Rahman S.Z., Anwar W.A., Abdel-Aal W.E., Mostafa H.M. Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 1998, 22:129-138.
56. Sunaga N., Kohno T., Yanagitani N., Sugimura H., Kunitoh H., Tamura T., et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 2002, 11:730-738.